Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | PF-06747143 |
| Trade Name | |
| Synonyms | PF 06747143|PF06747143 |
| Drug Descriptions |
PF-06747143 is a CXCR4 antagonist, which inhibits CXCR4 and CXCL12-mediated cell signaling, potentially resulting in cell death and inhibition of tumor cell metastasis (PMID: 28526063, PMID: 29296751). |
| DrugClasses | CXCR4 Inhibitor 15 |
| CAS Registry Number | NA |
| NCIT ID | C131572 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Azacitidine + Decitabine + PF-06747143 | Azacitidine Decitabine PF-06747143 | 0 | 1 |
| Bendamustine + PF-06747143 | Bendamustine PF-06747143 | 0 | 0 |
| Cytarabine + Daunorubicin + PF-06747143 | Cytarabine Daunorubicin PF-06747143 | 0 | 1 |
| PF-06747143 | PF-06747143 | 0 | 1 |